• Inicio
    • Presentación SEFIT
    • Junta de la Sociedad Española de Fitoterapia (SEFIT)
    • Grupos de trabajo
      • Clínica
      • Veterinaria
      • Calidad
  • Fitoterapia
    • Conceptos
    • Preguntas frecuentes – FAQ
  • Noticias
  • Actividades
    • Actividades SEFIT
      • Actividades programadas
      • Actividades anteriores
        • Índice de Presentaciones
        • Todas las Presentaciones
    • Otras actividades
  • Enlaces
  • Directorio
    • Asociados
    • Socios Corporativos
  • Área Privada
  • Asociarse

SEFIT

Sociedad Española de Fitoterapia

Usted está aquí: Inicio / Monografías ESCOP / Bulbo de ajo (Allii sativi bulbus, Garlic). Monografía online de ESCOP, 2019

Bulbo de ajo (Allii sativi bulbus, Garlic). Monografía online de ESCOP, 2019

15/07/2019 By Bernat Vanaclocha

European Scientific Cooperative On Phytotherapy. ESCOP monographs The Scientific Foundation for Herbal Medicinal Products. Online series. Allii sativi bulbus (Garlic). Exeter: ESCOP; 2019.

Allii sativi bulbus
Garlic
Allium sativum L.
Published 2019
Format: PDF. 29 pages

>> Ver online (30€/año, gratis para los socios de SEFIT)

>> Descargar (Pdf): 20€ para el público en general, 16€ para los socios de SEFIT

 

SUMMARY

The herbal monograph selects and summarises scientific studies and textbooks regarding efficacy, dosage and safety to support the therapeutic uses of garlic. This herbal drug by definition consists of the bulb of Allium sativum L., with the outer corneous layer removed, cut, freeze-dried or dried at less than 65ºC and powdered. It contains not less than 0.45 per cent of allicin.

Studies with its main characteristic constituents alliin, the main sulphur-containing amino acid, its conversion to allicin, S-methyl-L-cysteine sulphoxide and S-allyl-cysteine are included.

The therapeutic indications are prophylaxis of atherosclerosis; treatment of elevated blood lipid levels if insufficiently controlled by diet; supportive treatment of hypertension; reducing severity of upper respiratory tract infections and catarrhal conditions.

Administration of garlic addresses posology; its duration of use; contra-indications; special warnings; special precautions for use; interactions with other medicinal products; other forms of interaction; in pregnancy and lactation; its effects on ability to drive; undesirable effects; overdose.

In vitro experiments with garlic showed anti-atherosclerotic, lipid-lowering and antioxidant effects, as well as beneficial effects on vascular resistance, fibrinolysis and platelet aggregation. Antibacterial, antimycotic, antiviral, neuroprotective, antiparasitic and antitumour effects were also noted. In vivo experiments with garlic or its extracts demonstrated lipid-lowering, anti-atherogenic, antihypertensive, antioxidant and cardioprotective, as well as antiviral properties.

Pharmacological studies in humans concerned rheological, anti-atherosclerotic, lipid-lowering and antioxidant activities.

Regarding interactions with other medicinal products in humans, warfarin, fluindione, saquinavir and ritonavir, human studies confirmed most findings in rats.

Controlled clinical studies investigating effects on blood pressure were analysed in systematic reviews and meta-analyses. Results revealed that garlic was associated with reductions in blood pressure in patients with hypertension. A recent meta-analysis including 20 randomized, controlled trials showed a significant decrease in systolic as well as diastolic blood pressure compared with placebo. The summary of a systematic review of 45 randomized trials showed beneficial effects of garlic on several other cardiovascular-related factors, e.g. in patients with peripheral arterial occlusive disease, coronary arterial disease and hyper-cholesterolaemia. Lipid-lowering effects of garlic on total serum cholesterol were assessed in 7 meta-analyses, one of which evaluated 26 randomized double-blind, placebo controlled clinical trials. When placebo-controlled studies were conducted in combination with defined diets in patients with hyperlipidaemia, arterial occlusive disease, mild hypercholesterolaemia, mild hypertension and peripheral coronary heart disease, significant reductions in total cholesterol were found. With regard to prophylaxis of atherosclerosis, a 4 year study showed significant inhibition of the increase in plaque volume.

Pharmacokinetic properties were studied in various animal species, which assessed absorption, excretion and bioavailability of individual compounds. Preclinical safety data were assessed in toxicity studies. No mutagenicity was evident in the Ames test. Safety data originated from systematic reviews of human studies.

The selection of literature cited in the monograph is aimed at bringing together relevant information about the possible physiological roles of garlic and its major constituents.

KEYWORDS

  • Allii sativi bulbus
  • Garlic
  • Allium sativum L.
  • Prophylaxis of atherosclerosis
  • Elevated blood lipid levels
  • Supportive treatment of hypertension
  • Upper respiratory tract infections and catarrh

Publicado en: Monografías ESCOP

  • Correo electrónico
  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter

Grupos de trabajo

Sellos de Calidad

Web Médica Acreditada. Ver más información web de interés sanitario

Socios Corporativos

  • A.Vogel – Bioforce España
  • AlchemLife Iberia
  • Anastore Bio
  • Arafarma Group
  • Arkopharma
  • Atena Productos Farmacéuticos
  • Bechinatural Nutrition
  • Biosearch Life
  • Bioserum Laboratorios
  • Bonusan
  • Cien por Cien Natural
  • Deiters
  • Eladiet
  • Euromed
  • General Dietética-Integralia
  • Grupo Tegor
  • Kern Pharma
  • Laboratorio Ecológico Sana
  • Laboratoire Optim (Bionoto)
  • Martínez Nieto (Marnys)
  • Natac
  • Natur Import
  • Naturlider
  • Neovital Health
  • Novadiet
  • Pharma Nord España
  • Pharmactive Biotech Products
  • Pharmasor
  • PiLeje
  • Pirinherbsan
  • Pranarôm España
  • Sakai
  • Salus Floradix España
  • Select Botanical
  • Sincrofarm
  • SM Import
  • Terpenic Labs
  • Tradichem
  • Tricopharming
  • Ynsadiet

Entidades con las que tiene convenio SEFIT

  • Asociación Española para el estudio de la Menopausia (AEEM)
  • Centro de Estudios sobre Fitoterapia (INFITO)
  • Consejo Andaluz de Colegios Oficiales de Farmacéuticos (CACOF)
  • Consejo General de Colegios de Farmacéuticos de España
  • Estación Biológica Torretes, Jardín botánico
  • Sociedad Asturiana de Fitoterapia (SAF)
  • Sociedad Española de Médicos de Atención Primaria (SEMERGEN)
  • Universidad CEU – Cardenal Herrera
  • Universidad CEU – San Pablo
  • Universidad de Barcelona – IL3, postgrados de Fitoterapia y plantas medicinales
  • Universidad Francisco de Vitoria

SEFIT es miembro de:

  • Consejo Iberoamericano de Fitoterapia – Conselho Íbero-americano de Fitoterapia (CIAF) Consejo / Conselho Iberoamericano de Fitoterapia
  • ESCOP European Scientific Cooperative on Phytotherapy
sefit publicaciones acceso libre

Revista de Fitoterapia

Revista de Fitoterapia

La Revista de Fitoterapia es el órgano oficial de SEFIT

Monografías de ESCOP

Monografías de ESCOP

Acceso exclusivo para los socios de SEFIT

Suscríbete al Newsletter de SEFIT

noticias de fitoterapia

He leído y acepto la Política de privacidad

Tienes la posibilidad de darte de baja de esta lista desde el enlace que figura al pie de cada correo recibido.

Responsable de la web: Dr. Bernat Vanaclocha, Médico, Colegiado 464610887 (COM Valencia). NIF: 73941536D · Gestión de contenidos: Cita Publicaciones y Documentación SL
Mapa web · Copyright © 2025 · Esta página es propiedad de la Sociedad Española de Fitoterapia SEFIT (CIF: G97248579) · Aviso Legal · diseño web denou.com

Utilizamos cookies propias y de terceros para mejorar la experiencia de navegación, y ofrecer contenidos y publicidad de interés. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.Continuar Más información
Política de cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Siempre activado
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
GUARDAR Y ACEPTAR